Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference9 articles.
1. Lenalidomide: a review of its continuous use in patients with newly diagnosed multiple myeloma not eligible for stem-cell transplantation;Mccormack;Drugs Aging,2015
2. Continuous lenalidomide treatment for newly diagnosed multiple myeloma;Palumbo;N Engl J Med,2012
3. Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study;Chanan-Khan;J Clin Oncol,2006
4. Lenalidomide in the myelodysplastic syndrome with chromosome 5Q deletion;List;N Engl J Med,2006
5. Acute eosinophilic myocarditis mimicking myocardial infarction;Thambidoral;Tex Heart Inst J,2009
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management;Journal of Clinical Medicine;2024-03-09
2. Cardiac toxicities in multiple myeloma: an updated and a deeper look into the effect of different medications and novel therapies;Blood Cancer Journal;2023-05-19
3. Mechanisms of Myocardial Ischemia in Cancer Patients: A State-of-the-Art Review of Obstructive Versus Non-Obstructive Causes;Reviews in Cardiovascular Medicine;2022-06-24
4. Combined lenalidomide/bortezomib for multiple myeloma complicated by fulminant myocarditis: a rare case report of widely used chemotherapy;European Heart Journal - Case Reports;2022-02-22
5. Myocarditis in Cancer Patients: A Review of an Emerging Problem in Cardio-Oncology;ABC: Heart Failure & Cardiomyopathy;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3